Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Persistence Targeted Smoking Cessation in Schizophrenia (PTSC-S)

NCT03873337 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT03873337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03873337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Persistence Targeted Smoking Cessation in Schizophrenia (PTSC-S)
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Not applicable
Overall status
Completed
Start date
April 22, 2019
Completion date
January 31, 2022
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia, tobacco smoking, tobacco use, tobacco use cessation, tobacco use disorder